Patent rights refer to the right to exclude other people. That is the whole of it, and it is narrower than most people expect.

A patent does not give you permission to practise your own invention. It gives you the ability to stop others practising what your claims cover.

Those are different things and the gap between them has caught out a great many inventors who assumed a granted patent meant they were clear to launch.

Rights are also national, time-limited, and lost more often than kept.

What the right actually is

Patent rights are Patent rights are not
A right to exclude A right to practise
National Global
Time-limited Perpetual
Defined by the claims Defined by the description
Enforceable after grant Enforceable while pending
Lost if fees go unpaid Automatic once granted

The right to exclude is negative by design. It restrains others; it does not authorise you.

The five activities

Activity Covered
Making Manufacturing the claimed invention
Using Operating or employing it
Selling Transferring it for value
Offering for sale Even without a completed sale
Importing Bringing it into the country

Each is independent. Importing an infringing product infringes even where it was manufactured lawfully in a country with no corresponding patent.

Offering for sale counts on its own. A price list or a quotation can infringe without any product changing hands.

Which is why importation matters strategically. A US patent reaches goods made abroad at the point they enter the country.

Why you can hold a patent and still infringe

Two patents can both be valid and overlap.

Situation Result
You patent an improvement Valid
Someone else holds a patent on the base invention Also valid
Your improvement requires the base You infringe theirs
They cannot practise your improvement They infringe yours
Practical outcome Cross-licence, or neither ships

Blocking patents are ordinary, not a defect. Improvement patents that cannot be practised without a licence to the underlying invention are common in every field.

Which is why a patent is not clearance. Clearance is a freedom-to-operate analysis, and it is a different exercise entirely. See freedom to operate.

Rights before grant

Stage Enforceable rights
Idea None
Provisional filed None — a priority date only
Non-provisional pending None
Published at 18 months Provisional rights, narrowly
Granted Full right to exclude

Provisional rights require actual notice and granted claims substantially identical to the published ones. In practice they rarely produce recovery.

"Patent pending" confers no rights. It signals that an application exists, which has deterrent value and no legal force. See patent is pending.

Rights are geography-specific

Patent granted by Rights in
USPTO The United States only
EPO, then validated Each validated state separately
CNIPA China only
JPO Japan only
Nowhere Nowhere

There is no world patent. The PCT is a filing route that defers national decisions; it does not grant anything.

European patents fragment at grant. Validation in each designated state creates a national right with its own annuity, so one European patent can be alive in three countries and lapsed in four.

Manufacturing jurisdictions are undervalued. Coverage where a product is made can reach the supply chain rather than chasing distribution. See patent annuity fees by country.

Duration

Type Term Fees
Utility 20 years from earliest non-provisional filing Three
Design 15 years from grant None
Plant 20 years from filing None
Adjustment Effect
Patent Term Adjustment Adds days for USPTO delay
Patent Term Extension Up to 5 years, regulated products
Terminal disclaimer Caps the term to an earlier patent
Continuation chain Runs from the earliest parent

Continuations are the common miscalculation. A patent filed in 2024 as a continuation of a 2016 application expires in 2036, not 2044.

Check Related U.S. Application Data on the front page before calculating anything. See patent life.

Rights end more often by fee than by expiry

Fee Due after grant Large Small Micro
First 3.5 years $2,150 $860 $430
Second 7.5 years $4,040 $1,616 $808
Third 11.5 years $8,280 $3,312 $1,656
Total $14,470 $5,788 $2,894
Ipiry Patent Survival Curve v1.0 Rate
Survive the 3.5-year fee (2022 cohort) 85.8%
Survive the 7.5-year fee (2018 cohort) 64.6%
Reach full term (2014 cohort) 41.4%
Abandoned before full term 58.6%

Computed from 27,273,654 USPTO maintenance fee records covering 8,262,336 US utility patents — see the patent survival curve.

Nearly three in five sets of US patent rights end early, by decision rather than by expiry.

Infringement does not require copying

Right Independent creation a defence?
Patent No
Copyright Yes
Trade secret Yes
Trademark Sometimes, on confusion analysis

This is what makes patent rights unusually strong. A competitor that never heard of your patent and developed the same solution independently still infringes.

It also means your own independent development is no defence against someone else's patent, which is the reason freedom-to-operate work exists.

What rights do not reach

Activity Covered?
Making the invention abroad Not by a US patent
Importing the product into the US Yes
Purely private, non-commercial use Technically covered; rarely pursued
Certain regulatory-approval activity Statutory safe harbour
Independent invention Covered — no defence
Prior commercial use, in limited cases Possible defence

The regulatory safe harbour matters in pharmaceuticals. Activity reasonably related to obtaining FDA approval is protected, which is what enables generic development before patent expiry.

Prior commercial use is a narrow defence, available in defined circumstances to a party that commercially used the invention before the patent's effective filing date.

Who holds them

Situation Initial holder
Default The inventors
Employee, with a written assignment The employer
Employee, no written assignment Potentially the employee
Contractor, no written assignment Frequently the contractor
After assignment The assignee
Joint inventors, no agreement Each may license the whole

Contractor gaps are the most common ownership defect found in diligence. Paying for work does not buy the rights in it.

Use present-tense language. "Hereby assigns" operates immediately; "agrees to assign" creates only an obligation. See intellectual property assignment.

Enforcing them

Requirement Detail
Standing Owner, or a licensee holding substantially all rights
Patent in force At the time of the infringement
Marking Limits damages if products are unmarked
Six-year cap On past damages
Forum District court, or the ITC for importation

Rights unenforced are still rights, and enforcement is a separate decision with its own economics. Litigation costs millions and puts the patent at risk of invalidation.

Marking is the cheap step. It starts the damages period without a notice letter and without inviting a declaratory judgment action. See patent marking.

Transferring rights

Route Ownership Fees stay with
Assignment Transfers permanently The buyer
Exclusive licence Stays The owner
Sole licence Stays The owner
Non-exclusive licence Stays The owner
Covenant not to sue Stays The owner

Only assignment ends the ongoing obligations. Licensing keeps maintenance fees, enforcement and validity risk with the owner.

Record assignments promptly, in every jurisdiction where rights exist. See assignment search.

Worked example: a granted patent that could not be used

A company patents an improved valve seal and prepares to launch.

Step Finding
Their patent granted Valid, claims allowed
Assumption "We own it, so we can sell it"
FTO search before launch Third-party patent on the valve body
Their seal requires that body They infringe
Options Licence, design around, or challenge
Their own patent Still valuable — blocks the other party too
Rights they hold To exclude others from the seal
Rights they do not hold To practise the complete valve
Resolution Cross-licence

Both patents were valid throughout. Nothing was wrong with either.

The mistake was treating a grant as clearance. Two weeks of FTO work before launch would have found it while design changes were still cheap.

What the claims decide

Rights are the entitlement To exclude
Claims define the scope What specifically you can exclude
Broad claims More rights
Narrow claims Fewer, easier to design around
Invalidated claims No rights at all

Reading the claims is how you find out what rights are worth. A patent with narrow claims nobody would infringe confers rights over nothing anyone wants to do. See patent claim.

Before relying on any patent rights

Check Source Time
In force? USPTO Patent Center 3 min
Who owns it? USPTO Assignment Search 5 min
Remaining term Front page + PTA + family 5 min
What the claims cover The claims Longer
Survived any challenge? PTAB records 10 min

Twenty minutes, all free. A substantial share of the patents people worry about turn out to be expired, sold, or narrowed. See patent status.

Rights across IP types

Patent Copyright Trade secret Trademark
Independent creation a defence No Yes Yes Sometimes
Registration required Yes No None exists Usually
Duration 20 yrs from filing Long While secret Indefinite
Territorial Yes Largely By contract Yes

Patents are the only right where independent creation is no defence, which is what makes them strong and what makes freedom-to-operate work necessary.

Patent rights: the checklist

  1. A patent is a right to exclude, never a right to practise.
  2. Run freedom-to-operate work separately. A grant is not clearance.
  3. All five activities count — make, use, sell, offer, import.
  4. Remember importation reaches goods made abroad.
  5. Rights are national. File where the market and the manufacturing are.
  6. Calculate term from the earliest non-provisional filing in the chain.
  7. Pay the maintenance fees. 58.6% of rights end this way.
  8. Get written assignments from employees and contractors, in present tense.
  9. Read the claims. They decide what the rights are actually worth.
  10. Verify status and ownership before relying on or worrying about any patent.